Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Barnes, Thomas RE, and Schizophrenia Consensus Group of the British Association for Psychopharmacology. "Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology." Journal of Psychopharmacology 25, no. 5 (2011): 567-620.

Wu, Mengqian, Nanya Hao, and Dong Zhou. "Spermatorrhea and loss of libido induced by topiramate: first case report and review of literature." Clinical neuropharmacology 39, no. 6 (2016): 325-326.

Haddad, Peter M., Cecilia Brain, and Jan Scott. "Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies." Patient related outcome measures 5 (2014): 43.

Ochoa, Juan G. "Topiramate improves psychiatric symptoms in a patient with Lewy body dementia." Cognitive and Behavioral Neurology 27, no. 4 (2014): 222-223.

Howes, Oliver, Rob McCutcheon, and James Stone. "Glutamate and dopamine in schizophrenia: an update for the 21st century." Journal of psychopharmacology 29, no. 2 (2015): 97-115.

Chandradasa, Miyuru, Layani Champika, Silumini de Silva, and K. A. L. A. Kuruppuarachchi. "Topiramate’s effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial." Trials 18, no. 1 (2017): 1-8.

Martins-de-Souza, Daniel, Murtada Alsaif, Agnes Ernst, Laura W. Harris, Nancy Aerts, Ilse Lenaerts, Pieter J. Peeters et al. "The application of selective reaction monitoring shows dysregulation of glycolysis in a preclinical model of schizophrenia." (2012).

Agarwal, Sri Mahavir, and Ganesan Venkatasubramanian. "Metabolic syndrome in schizophrenia: Theoretical, clinical and translational perspectives." Indian journal of psychological medicine 35, no. 2 (2013): 117.

Levin, Jennifer. "Roche provides update on the first two of six phase III studies of bitopertin in schizophrenia."

Freudenreich, Oliver. "Clozapine." Psychotic Disorders (2020): 231-248.

Kouidrat, Youssef, Ali Amad, and Marc De Hert. "Emerging drugs and indications for cardio-metabolic disorders in people with severe mental illness." Current pharmaceutical design 21, no. 23 (2015): 3317-3324.

Mandolini, Gian Mario, Matteo Lazzaretti, Alfredo Carlo Altamura, and Paolo Brambilla. "Substances of Abuse and Hallucinogenic Activity: The Glutamatergic Pathway-Focus on Ketamine." In Hallucinations in Psychoses and Affective Disorders, pp. 33-41. Springer, Cham, 2018.

Wegener, Gregers. "Updated Practice Guidelines for the Use of Clozapine in Adult Individuals with Intellectual Disabilities." (2016).

Okuyama, Yuji, Kazuto Oya, Shinji Matsunaga, Taro Kishi, and Nakao Iwata. "Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials." Neuropsychiatric disease and treatment 12 (2016): 3221.

Krzystanek, Marek, Krzysztof Krysta, Mariusz Borkowski, Katarzyna Ska?acka, Jacek Przyby?o, Artur Pa?asz, Davor Mucic, Ewa Martyniak, and Napoleon Waszkiewicz. "The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study." Journal of Clinical Medicine 9, no. 11 (2020): 3681.

Kowalchuk, Chantel, Laura N. Castellani, Araba Chintoh, Gary Remington, Adria Giacca, and Margaret K. Hahn. "Antipsychotics and glucose metabolism: how brain and body collide." American Journal of Physiology-Endocrinology and Metabolism 316, no. 1 (2019): E1-E15.

Kane, John M., and Christoph U. Correll. "Benign Ethnic Neutropenia and Clozapine Use." J Clin Psychiatry 77, no. 7 (2016): e909-e916.

Lee, Jung Sun, Jun Soo Kwon, Daeho Kim, Sung-Wan Kim, Jae-Jin Kim, Jong-Hoon Kim, Hee Jung Nam et al. "Prevalence of metabolic syndrome in patients with schizophrenia in Korea: a multicenter nationwide cross-sectional study." Psychiatry investigation 14, no. 1 (2017): 44.

Reser, Maree. "Investigating factors that influence cognitive response to, and the efficacy of, cognitive remediation therapy in people with schizophrenia." PhD diss., Swinburne University of Technology, 2018.

Corriveau, Jennifer A. "Age, Experience, and NMDA Antagonism: Dynamic Regulation of Parvalbumin Expression in Normal and Chronically Ketamine-Treated Rats." (2015).